Head to head
Cardinal Health vs McKesson
Side-by-side on the measures that matter, with a plain-English read. Full detail: CAH · MCK
CAH
Cardinal Health
272.81+0.17%
1-year price shape — +32% over the period
Quant Rating C · 75/100
vs
MCK
McKesson
1,069.43+0.68%
1-year price shape — +26% over the period
Quant Rating C · 67/100
1-year performance, rebased to 100
McKesson edges it on the scoreable measures. McKesson trades cheapest on trailing earnings; McKesson earns the most per share.
| CAH | MCK | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Distribution | -- |
| Last price | 272.81 | 1,069.43 |
| Change today | +0.17% | +0.68% |
| 1-year return | +32.4% | +26.4% |
| Market cap | $63.06B | $123.47B |
| 52-week range | 179.64 – 286.29 | 722.11 – 1,121.50 |
| Valuation | ||
| P/E (TTM) | 35.29 | 27.48 |
| P/E percentile, own 5-yr range | 72nd | 73rd |
| P/B | -20.84 | -31.23 |
| Dividend yield | 0.75% | 0.32% |
| Profitability & growth | ||
| EPS (TTM) | 7.23 | 38.55 |
| Net profit (TTM) | $1.67B | $4.45B |
| Revenue (TTM) | $257.75B | $418.79B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +5.5% | +7.6% |
| Gross margin | 3.9% | 3.7% |
| Operating margin | 1.3% | 1.7% |
| Net margin | 0.7% | 1.1% |
| Free cash flow (TTM) | $4.90B | $6.87B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 90.5% | 89.2% |
| Insider activity (12mo) | 26 buy / 24 sell | 21 buy / 27 sell |
| Short interest (% of float) | 3.3% | 1.7% |
| Analyst consensus | 92% buy / 8% hold (12) | 90% buy / 10% hold (10) |
| Analyst price target | $303 (+11%) | $1,211 (+13%) |
| StockVane view | ||
| StockVane Quant Rating | C (75) | C (67) |
| Company | ||
| Employees | 63,900 | 43,000 |
| Founded | 1979 | 1833 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.